Flotegatide-F18

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameFlotegatide-F18
Drug Alias NameRGD-F18
ClassificationBiologics
Mechanisms of ActionIntegrin alpha-V/beta-3 stimulantsPositron-emission tomography enhancers
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsMetastatic breast cancerHigh-Grade GliomaCarotid Stenosis +[10
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerHigh-Grade GliomaCarotid Stenosis +[10

Other Information

ATC CodeN/A
Related LinksN/A